Pharmacology of leukotriene receptor antagonists: More than inhibitors of bronchoconstriction

Chest

Volumn 111, Issue 2 SUPPL., 1997, Pages 35S-45S

  Hay, Douglas W P ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

asthma; cysteinyl leukotriene receptor antagonists; cysteinyl leukotrienes; montelukast; pranlukast; zafirlukast

Indexed keywords

1 [2 METHOXY 4 [(PHENYLSULFONYLAMINO)CARBONYL]BENZYL] 1H INDAZOLE 6 CARBAMIC ACID CYCLOPENTYL ESTER; 2 [4 [2 (5 TETRAZOLYLMETHYL)BENZYLOXY]PHENOXYMETHYL]QUINOLINE; 4 [4 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY)PROPYLTHIO]PHENYL] 4 HYDROXY 3 METHYLBUTYRIC ACID; 7 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY) 2 HYDROXYPROPOXY] 4 OXO 8 PROPYL 4H 1 BENZOPYRAN 2 CARBOXYLIC ACID; HISTAMINE; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; MEPYRAMINE MALEATE; MONTELUKAST; PEPTIDOLEUKOTRIENE; POBILUKAST; PRANLUKAST; TOMELUKAST; VERLUKAST; ZAFIRLUKAST;

AEROSOL; ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS MUCUS; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION TEST; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG FUNCTION TEST; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION;

EID: 0031056743     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Drazen JM, Austen KF. Leukotrienes and airway responses. Am Rev Respir Dis 1987; 136:985-98
2. Piacentini GL, Kaliner MA. The potential roles of leukotrienes in bronchial asthma. Am Rev Respir Dis 1991; 143:S96-99
3. Summers JB. Inhibitors of leukotriene biosynthesis. Drugs News Perspective 1990; 3:517-26
4. Brocklehurst WE. The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J Physiol (Lond) 1960; 151:416-35
5. 4. Proc Natl Acad Sci USA 1983; 80:1712-16
6. Arm JP, Lee TH. Sulphidopeptide leukotrienes in asthma. Clin Sci 1993; 84:501-10
7. Busse W. Mechanisms of inflammation and their therapeutic implications in the asthmatic patient. Ann Allergy 1992; 69:261-66
8. Hay DWP, Torphy TJ, Undem BJ. Cysteinyl leukotrienes in asthma: old mediators up to new tricks. Trends Pharmacol Sci 1995; 16:304-09
9. Cristol JP, Provencal B, Sirois P. Leukotriene receptors. J Recept Res 1989; 9:341-67
10. Crooke ST, Sarau H, Saussy D, et al. Signal transduction processes for the LTD., receptor. Adv Prostaglandin Thromboxane Leukot Res 1990; 20:127-37
11. Krell RD, Aharony D, Buckner CK, et al. Peptide leukotriene receptors and antagonists. Adv Prostaglandin Thromboxane Leukot Res 1990; 20:119-26
12. Hay DW, Muccitelli RM, Tucker SS, et al. Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways. J Pharmacol Exp Ther 1987; 243:474-81
13. Buckner CK, Fedyna JS, Robertson JL, et al. An examination of the influence of the epithelium on contractile responses to peptidoleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways. J Pharmacol Exp Ther 1990; 252:77-85
14. 4. J Pharmacol Exp Ther 1986; 237: 558-62